Biotech Industry News
A collection of Biotech latest news, analysis and best practices from top business influencers and the world's most trustworthy sources.
Hedge Fund Regal Hit by 93% Crash in Australian Biotech Stock
Sydney hedge fund Regal Partners Ltd. was dealt a fresh blow after Immutep Ltd., an Australian biotech company it backs, wiped out most of its A$582 million ($412 million) market value on Friday when it halted trials of a lung cancer drug. Immutep…
Biotech Stock Up 365% as This $8 Million Investment Targets a Drug With 3 NDA Filings Planned
Sphera Funds Management disclosed a buy of 279,974 shares of Cogent Biosciences (COGT 2.08%) in a February 17, 2026, SEC filing, an estimated $7.87 million transaction based on quarterly average pricing. According to its SEC filing dated February…
Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings
On February 17, 2026, Driehaus Capital Management disclosed a buy of 432,510 shares of Praxis Precision Medicines (PRAX +2.96%), an estimated $80.54 million trade based on quarterly average pricing. According to an SEC filing dated February 17…
This Fund Bet $200 Million on a Biotech Stock Up 50% as Kidney Disease Drug Targets July 7 FDA Decision
Deerfield Management Company disclosed a buy of 418,538 shares of Vera Therapeutics (VERA +0.22%) in its February 17, 2026, SEC filing, with an estimated transaction value of $14.87 million based on the quarter's average price. According to a…
This Fund Has a $200 Million Bet on a Biotech Stock Up 30% in Days After Phase 3 Breakthrough
On February 17, 2026, Driehaus Capital Management disclosed a buy of Xenon Pharmaceuticals (XENE +0.26%), adding 369,577 shares in an estimated $15.52 million trade based on quarterly average pricing. According to an SEC filing dated February 17…
Inside One Fund's $170 Million Bet on a Biotech Stock Up 1,040% in a Year Amid FDA Review for Breast Cancer Drug
Deerfield Management Company disclosed a substantial purchase of Celcuity (CELC +3.79%) in its February 17, 2026, SEC filing, adding 980,470 shares in the fourth quarter. The estimated value of the trade is $80.60 million, based on average pricing…
From a start-up biotech firm to a global vaccine giant
What started as a small biotech start-up in Shamirpet's Genome Valley 30 years ago has now emerged as a major global vaccine company. Krishna Ella, the Co-Founder of Bharat Biotech, incidentally also helped groom the valley, which now houses some…
Sana Biotechnology (NASDAQ:SANA) Trading Up 7.8% - Here's What Happened
Shares of Sana Biotechnology, Inc. (NASDAQ:SANA - Get Free Report) were up 7.8% during mid-day trading on Friday. The stock traded as high as $3.30 and last traded at $3.3310. Approximately 939,320 shares traded hands during trading, a decline of…
Pharmalittle: We're reading about Trump and drug prices, biotechs pushing back, and more
And so, another working week will soon draw to a close. Not a moment too soon, yes? This is, you may recall, our treasured signal to daydream about weekend plans. Our agenda is, so far, rather modest. We expect to catch up on our reading, take a…
Rapid Micro Biosystems: Big Pharma Adoption Driving Growth (NASDAQ:RPID)
Rapid Micro Biosystems, Inc. posted strong FY25 revenue growth, driven by Growth Direct system placements, but remains unprofitable with a $47M net loss. RPID's growth hinges on large multi-system orders from major pharmaceutical manufacturers…
Capital International Investors Sells 140,873 Shares of Legend Biotech Corporation Sponsored ADR $LEGN
Capital International Investors decreased its stake in shares of Legend Biotech Corporation Sponsored ADR (NASDAQ:LEGN - Free Report) by 13.0% in the third quarter, according to the company in its most recent Form 13F filing with the SEC. The fund…
Is Bio-Techne Stock a Buy, Sell, or Hold After a Wealth Manager Dumps Its Entire Stake?
According to a Feb. 17, 2026, SEC filing, Hollow Brook Wealth Management LLC sold out its entire position in Bio-Techne (TECH 1.03%) during the fourth quarter of 2025. The fund divested 174,677 shares, with an estimated transaction value of $10.7…
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline
On February 17, 2026, Deerfield Management Company disclosed a buy of Praxis Precision Medicines (PRAX +0.75%), adding 62,500 shares in a trade estimated at $11.64 million based on quarterly average pricing. According to a filing with the U.S.
Jim Cramer on Recursion Pharmaceuticals: 'It's a Let Down, Big Let Down'
Recursion Pharmaceuticals, Inc. (NASDAQ: RXRX) is one of the stocks Jim Cramer answered questions about. When a caller mentioned that Cathie Wood invested in the stock, Cramer remarked, “That's, it's a let down, big let down. Came on the…
These Genetically Engineered Brain Cells Devour Toxic Alzheimer's Plaques
Biotechnology A single shot protected mice from the protein gunk implicated in Alzheimer's disease. Astrocytes (green) surround amyloid beta (blue) / Yun Chen Alzheimer's disease and cancer have something in common: They're hard to treat. Despite…
Receive a Daily briefing on Biotech Industry News
Get Started